| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 02/17/2005 | WO2005014779A2 Cyclodextrin affinity purification |
| 02/17/2005 | WO2005014640A1 Method of peptide synthesis |
| 02/17/2005 | WO2005014621A1 Method for the purification of a non-immunoglobulin protein comprising an immunoglobulin-like (ig-like) domain |
| 02/17/2005 | WO2005014620A1 Ligation method |
| 02/17/2005 | WO2005013899A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 02/17/2005 | WO2005013889A2 Truncated fragments of alpha-synuclein in lewy body disease |
| 02/17/2005 | WO2004104548A3 Solution phase electrophoresis device, components, and methods |
| 02/17/2005 | WO2002074913A3 Nucleic acid-associated proteins |
| 02/17/2005 | US20050039220 Labeled coronavirus protein for use as diagnostic tool in detection of viral infection; viricides and vaccine development for treatment and prevention of respiratory system disorders |
| 02/17/2005 | US20050038610 Apparatus and method for automated protein design |
| 02/17/2005 | US20050037486 Multicompartment apparatus for reformation of functional proteins; bioreactors and protein engineering |
| 02/17/2005 | US20050037474 Method for controlling the yield and purity of proteinase inhibitor II during extraction |
| 02/17/2005 | US20050037435 Generating new compounds without predetermining a desired structure or composition; rational drug design |
| 02/17/2005 | US20050037415 Using transgenic cells as tools in identifying therapeutic amino acids; mimetic peptides; drug screening |
| 02/17/2005 | US20050037385 Genetically engineered protein comprising multiple zinc finger domains for use as regulatory quadruplets in gene expression analysis |
| 02/17/2005 | US20050037359 Differentiating and identifying polynucleotides and/or polypeptides via binding to large scale integrated circuit (LSI); non-radioacitve labeling of biopolymers |
| 02/17/2005 | US20050036948 Radiolabeled annexins |
| 02/17/2005 | US20050034990 System and method for electrokinetic trapping and concentration enrichment of analytes in a microfluidic channel |
| 02/17/2005 | US20050034989 Mixture of gel mincing tube and mesh; dividing; centrifuging; drawing through porous material |
| 02/17/2005 | DE10333368A1 Multifunktionell-verknüpfungsfähige und spaltbare Festphasenreagenzien und Verfahren zu deren Herstellung Multi-functional-link-able and cleavable solid phase reagents and methods for their preparation |
| 02/17/2005 | CA2844154A1 Polysaccharide-protein conjugate vaccines |
| 02/17/2005 | CA2537555A1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 02/17/2005 | CA2534520A1 Oligopeptide ligation methods comprising an activated ester moiety or an aldehyde or ketone moiety |
| 02/17/2005 | CA2534412A1 Conjugates of a polymer and a protein linked by an oxime linking group |
| 02/17/2005 | CA2534143A1 Method of peptide synthesis |
| 02/17/2005 | CA2532721A1 Ra antigenic peptides |
| 02/17/2005 | CA2530497A1 Improved electrophysiological assays using oocytes that express human enac and the use of phenamil to improve the effect of enac enhancers in assays using membrane potential reporting dyes |
| 02/17/2005 | CA2526900A1 Truncated fragments of alpha-synuclein in lewy body disease |
| 02/17/2005 | CA2524767A1 Cyclodextrin affinity purification |
| 02/16/2005 | EP1506218A2 Reversible modification of membrane interaction |
| 02/16/2005 | EP1506217A2 Methods of identifying genomic and proteomic biomarkers for cystic fibrosis, arrays comprising the biomarkers and methods of using the arrays |
| 02/16/2005 | CN1582296A Template-fixed peptidomimeticsas inhibitors of serine proteases |
| 02/16/2005 | CN1189559C Preparation of analogue thrombase from venin by separation and purification |
| 02/16/2005 | CN1189480C Overreationg factor as well as its preparation factor and gene |
| 02/16/2005 | CN1189475C Process for separating and purifying FSH and corpus luteum hormone |
| 02/15/2005 | US6855807 Heterodimeric opioid G-protein coupled receptors |
| 02/10/2005 | WO2005012914A2 Method for characterising polypeptides by maldi-tof mas spectrometry |
| 02/10/2005 | WO2005012332A1 Spatially-defined macrocycles incorporating peptide bond surrogates |
| 02/10/2005 | WO2005012247A1 Compounds and methods for the rapid quantitative analysis of proteins and polypeptides |
| 02/10/2005 | WO2004113362A3 Libraries containing heterocyclic organic molecules prepared through intramolecular formation of n-acyliminium ions |
| 02/10/2005 | WO2004094462A3 Methods of peptide preparation |
| 02/10/2005 | WO2004083807A3 Methods of evaluating glycomolecules for enhanced activities |
| 02/10/2005 | WO2004067551A3 Method for identifying peptides by mass spectrometry |
| 02/10/2005 | WO2004024068A3 Novel composition and methods for the treatment of immune related diseases |
| 02/10/2005 | WO2003050295A3 Assays and implements for determining and modulating hsp90 binding activity |
| 02/10/2005 | US20050033522 Computer-based model for identification and characterization of non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors |
| 02/10/2005 | US20050033035 Mutants of igf binding proteins and methods of production of antagonists thereof |
| 02/10/2005 | US20050032709 Anti-hypertensive molecules and process for preparation thereof |
| 02/10/2005 | US20050032676 Administering lipidated glycopeptide antibiotic and cyclodextrin, reduced tissue accumulation of the glycopeptide antibiotic, reduced nephrotoxicity and reduced histamine release |
| 02/10/2005 | US20050032202 Device and method useable for integrated sequential separation and enrichment of proteins |
| 02/10/2005 | US20050032189 Novel protein derived from agkistrodon saxatilis emelianov and process preparing the same |
| 02/10/2005 | US20050032174 Multimeric protein for use in the treatment and prevention of infection and bleeding disorders |
| 02/10/2005 | US20050032157 Folded recombinant catalytic fragments of multidomain serine proteases, preparation and uses thereof |
| 02/10/2005 | US20050032153 Storable urea-based peptide processing solution comprising glycinamide, histidine, and/or 4-hydroxy proline for use in prevention of carbamylation of proteins; enhancing shelf life of urea containing process solutionsby preventing formation of cyanates |
| 02/10/2005 | US20050032149 Enzyme catalyzed isotope labeling |
| 02/10/2005 | US20050032134 Neoplasm-specific polypeptides and their uses |
| 02/10/2005 | US20050032113 Membrane protein library for proteome analysis and method for preparing same |
| 02/10/2005 | US20050032078 Methods for the detection, analysis and isolation of nascent proteins |
| 02/10/2005 | US20050031627 Methods for preparing immunoconjugates |
| 02/10/2005 | US20050031604 Secreted by serpent venom glands; endogenous vasopeptidase inhibitors; angiotensin converting enzyme inhibitors; vasodilating and anti-hypertensive action; bradykinins; mass spectrometry |
| 02/10/2005 | US20050031584 Interleukin-2:remodeling and glycoconjugation of interleukin-2 |
| 02/10/2005 | CA2574733A1 Method for the production of cyclic molecules |
| 02/10/2005 | CA2533823A1 Process for preparation of flax protein isolate |
| 02/10/2005 | CA2533820A1 Spatially-defined macrocycles incorporating peptide bond surrogates |
| 02/10/2005 | CA2533818A1 Spatially-defined macrocyclic compounds useful for drug discovery |
| 02/10/2005 | CA2533102A1 Method for characterising polypeptides by maldi-tof mas spectrometry |
| 02/09/2005 | EP1504111A2 Nucleic acid-peptide display libraries containing peptides with unnatural amino acid residues, and methods of making same |
| 02/09/2005 | EP1504026A2 Therapeutic polypeptides, nucleic acids encodings same, and methods of use |
| 02/09/2005 | EP1504022A2 Process for the synthesis of peptide amides by side-chain attachment to a solid phase |
| 02/09/2005 | EP1503836A2 Multi-layered macromolecules and methods for their use |
| 02/09/2005 | EP0383799B2 Adheson variants |
| 02/09/2005 | EP0365597B2 Improved processes for the treatment of vascular disease |
| 02/09/2005 | CN1576281A Viral clearance process |
| 02/09/2005 | CN1188171C Method of preventing aggregation of various substances upon rehydration or thawing and compositions obtained thereby |
| 02/08/2005 | US6852848 Nucleotide sequences coding polypeptides for use in the diagnosis, treatment and prevention of cancer, skin, vascular, kidney and inflammatory disorders |
| 02/08/2005 | US6852833 Artificial chaperon kit |
| 02/08/2005 | US6852818 Molecularly imprinted polymers produced by template polymerization |
| 02/08/2005 | US6852700 Colostrinin, and uses thereof |
| 02/08/2005 | US6852513 Solid phase synthesis; catalysis without secondary reactions |
| 02/08/2005 | US6852230 Method for the manufacture of compositions containing low concentrations of salts |
| 02/03/2005 | WO2005010520A1 Pre-cast electrophoresis slab gels from supplemented monomer solutions |
| 02/03/2005 | WO2005010165A2 Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof |
| 02/03/2005 | WO2005009981A1 Multifunctional linking and cleavable solid-phase reagents and method for the production thereof |
| 02/03/2005 | WO2005009378A2 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 02/03/2005 | WO2005009363A2 Treatment of pre-cancerous conditions and prevention of cancer using pcdgf-based therapies |
| 02/03/2005 | WO2005009225A2 Tissue adhesive sealant |
| 02/03/2005 | WO2005009217A2 Diagnosis of pre-cancerous conditions using pcdgf agents |
| 02/03/2005 | WO2004103519A3 External gradient chromatofocusing |
| 02/03/2005 | WO2003064620A3 Hepsin substrates and prodrugs |
| 02/03/2005 | US20050027457 Biosynthesis of amino acid sequences; rearrangement of peptide; ; |
| 02/03/2005 | US20050027111 Using multicompartment microfluidic apparatus to isolate/purify/separate to or more polypeptides in solution; electrophoresis and protein separation |
| 02/03/2005 | US20050027109 Preparing genetically engineered therapeutic protein fusion comprised of antibody constant region for use in treatment of metabolic disorders |
| 02/03/2005 | US20050027104 Antibodies for use in diagnosis, prevention and treatment of autoimmune disease |
| 02/03/2005 | US20050027102 Preparing biopolymer matrices that are selective for a particular compound; molecular imprinting |
| 02/03/2005 | US20050027101 Attachment and elaboration strategies for inverse peptide synthesis |
| 02/03/2005 | US20050027100 Membrane anchoring onto crosslinked polyacrylamide; biosensors; automatic peptide/protein synthesis |
| 02/03/2005 | US20050026834 Methods for making proteins containing free cysteine residues |
| 02/03/2005 | US20050026820 reducing nephrotoxicity; increased therapeutic window for the glycopeptide to allow a greater amount to be administered |
| 02/03/2005 | US20050025740 Polyoxime compounds and their preparation |
| 02/03/2005 | CA2533551A1 Tissue adhesive sealant |